Monday, March 24, 2025

March 24, 2025 at 02:23PM HIZENTRA

Product approval information is indicated for treatment of primary immunodeficiency (PI) in adults and pediatric patients 2 years of age and older.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/zcGYXmB

No comments:

Post a Comment